Summary
A bioRxiv preprint reports that TFAM-insufficient CD8⁺ T cells in influenza-infected mice were associated with lung immunopathology and weaker later immune responses, without improved viral control. The researchers also observed age-associated declines in TFAM expression and mitochondrial function in human CD8⁺ T cells.
A bioRxiv preprint reports that TFAM-insufficient CD8⁺ T cells in influenza-infected mice were associated with lung immunopathology and weaker later immune responses, without better viral control. The researchers also found an age-associated decline in TFAM expression and mitochondrial function in human CD8⁺ T cells. The human finding is observational; the consequences of reducing TFAM were tested in mice.
CD8⁺ T cells can kill infected cells and help establish immune memory. Mitochondrial transcription factor A (TFAM) helps maintain mitochondrial DNA and mitochondrial function. The study asks how that mitochondrial support affects the balance between antiviral activity and damage to lung tissue.
Human observations and mouse experiments
The researchers observed lower TFAM expression and mitochondrial function in human CD8⁺ T cells in association with age. To examine the consequences of TFAM insufficiency, they generated mice in which the condition was specific to CD8⁺ T cells and studied the animals during influenza infection.
In those mice, TFAM insufficiency disrupted mitochondrial integrity and energy metabolism, and was accompanied by increased mitochondrial DNA and oxidative stress. The affected T cells showed greater cytotoxic and inflammatory activity. That early response was associated with lung immunopathology, but did not improve control of the virus.
Early activity did not sustain later protection
The early increase in T-cell activity was followed by reduced effector function and diminished antigen-specific responses. In adoptive-transfer experiments, TFAM-insufficient cells provided less protection. The mice also had impaired heterosubtypic recall immunity—the capacity to mount a later protective response to a different influenza subtype.
Together, the findings suggest that strong early activity by CD8⁺ T cells is not necessarily a measure of durable antiviral protection. In this mouse model, TFAM-dependent mitochondrial fitness was linked both to limiting harmful lung inflammation and to sustaining later immune responses.
The study’s causal tests were conducted in a CD8⁺ T-cell-specific mouse model, while its human result was an age-associated observation. Whether that age-related pattern contributes to antiviral immune dysfunction in people remains unresolved. The report is a bioRxiv preprint.